Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 61 out of 100. Costs and economics

Topic: Risk, prevention and care in population studies

Plain-language summary

Introduction Extended nursing roles in dementia can improve treatment, care, and patient and caregiver outcomes. We tested the efficacy and cost-effectiveness in people living with dementia (PlwD) and caregivers. Methods We analyzed data from 417 PlwD within the multicenter, cluster-randomized InDePendent trial six months after baseline. Specifically, qualified nurses carried out advanced dementia care management individually tailored to each patient's and caregiver's needs. Outcomes included unmet needs (CANE), quality of life (QoL-AD, EQ-5D), caregiver burden (Zarit), and cost-effectiveness (FIMA, RUD). Results PlwD receiving the intervention had 74% lower unmet needs (0.26, CI 95% : 0.17 to 0.40, p 95% : 0.01 to 0.07, p = 0.017) than controls. There was a gain in quality-adjusted life years (0.01, CI 95% : -0.001 to 0.018) at slightly higher costs (1,425 EUR, CI 95% : 638 to 2,211). There was no effect on caregiver burden after six months. Discussion The results provide evidence for the efficacy and cost-effectiveness of extended nursing roles in dementia care, demonstrating that extended nursing roles reduce unmet needs and improve quality of life. Trial registration This trial was prospectively registered on ClinicalTrials.gov under the identifier NCT04741932 on February 2, 2021. Highlights The InDePendent intervention significantly reduced the number of unmet needs in PlwD and their caregiver according to CANE. Extended nursing roles can improve PlwD's health-related Quality of Life. Advanced dementia care management were likely to be cost-effective after six months.

What this study adds

Evidence grade: Moderate

The record lists 417 participants. In this cluster-randomized trial of 417 people living with dementia, those receiving extended nursing roles had 74% lower unmet needs and a gain in quality-adjusted life years of 0.01 at slightly higher costs of 1,425 EUR, with no effect on caregiver burden after six months. Reported effect size: Unmet needs rate ratio 0.26 (95% CI 0.17-0.40); QALY gain 0.01 at +1,425 euros.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Rädke, A., Michalowsky, B., Kleinke, F., Platen, M., Scharf, A., Pfaff, M., et al. (2025). Efficacy and cost-effectiveness of extended nursing roles in dementia care: Results of the cluster-randomized trial InDePendent. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70727

Vancouver

Rädke A, Michalowsky B, Kleinke F, Platen M, Scharf A, Pfaff M, et al. Efficacy and cost-effectiveness of extended nursing roles in dementia care: Results of the cluster-randomized trial InDePendent. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70727. PMID: 41143334.

BibTeX

@article{radke2025-41143334,
  author  = {Rädke, A. and Michalowsky, B. and Kleinke, F. and Platen, M. and Scharf, A. and Pfaff, M. and Buchholz, M. and Mühlichen, F. and Penndorf, P. and Schade, S. and Dombrowski, J. and Lerch, P. E. M. and others},
  title   = {{Efficacy and cost-effectiveness of extended nursing roles in dementia care: Results of the cluster-randomized trial InDePendent}},
  journal = {Alzheimer's \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz.70727},
  pmid    = {41143334},
  url     = {https://doi.org/10.1002/alz.70727}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.

Key findings

Why it matters

In this cluster-randomized trial of 417 people living with dementia, those receiving extended nursing roles had 74% lower unmet needs and a gain in quality-adjusted life years of 0.01 at slightly higher costs of 1,425 EUR, with no effect on caregiver burden after six months. The authors conclude this provides evidence for the efficacy and cost-effectiveness of extended nursing roles in reducing unmet needs and improving quality of life, not for treating or curing Alzheimer's disease.

Study details

Limitations

The CANE instrument may not cover all relevant need domains; results reflect only a six-month intervention; data validity may be limited by participants' cognitive impairment; data collection began before the last COVID-19 lockdown, which may have reduced healthcare use; and dementia was identified with the DemTect screening tool rather than a full diagnostic work-up, possibly including false positives.

How this study scored 61/100
How this study's score is builtJournal tier 9 of 10; Journal's citation record 2 of 4; Study design 11 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 2 of 4; Effect reported 3 of 3; Studied in people 3 of 3; Randomized / blinded 1 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 3 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 3 of 4; Institution's track record 0 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read left out, no data. 60 of the 98 points it could be judged on, which is 61 of 100. Total 61 of 100.60 of the 98 points we could judge = 61 of 100

Published in a leading specialty journal, and it is a randomized controlled trial. We have no data on free to read, so that was left out: it earned 60 of the 98 points we could judge it on, which is 61 out of 100.

ComponentPointsWhy
Journal tier 9 / 10 Tier 2 — leading specialty journal (Alzheimer's & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 11 / 12 A randomized controlled trial
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 2 / 4 417 participants
Effect reported 3 / 3 Effect reported with a statistic (interval, p-value, ratio or similar)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 1 / 2 Randomized (as stated in the record)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 3 / 6 Cited 4.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Wolfgang U. Hoffmann: h-index 57 (OpenAlex, whole career)
Institution's track record 0 / 3 Universität Greifswald: institution h-index 631 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41143334)
Free to read — / 2 Access not recorded — left out of this score
Points 60 / 98 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 60 of the 98 points we could judge it on is 61 out of 100.
Total 61 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Costs and economics from nearby years

Also tagged “nursing”

995 studies in the library carry the topic tag “nursing”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 995 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Costs and economics

See all studies in Costs and economics →